The pharmaceutical industry has made drug manufacturing even safer with the Oracle AERS, or Adverse Effect Reporting System. This aims to help pharmaceutical companies in managing the adverse events and reducing the risks associated with pharmaceutical drug use. The AERS has become the standard in monitoring and managing adverse drug reactions, helping the entire pharmaceutical business become more vigilant about drug safety.
While it is true that safety is the primary concern for all drug manufacturers, it must be noted that not all patients react the same way to the same drugs. Some patients may have little to no adverse reactions to a drug, but others may have mild to extreme adverse reactions to the same drug. Before these adverse drug reactions become a critical issue, something must be done about them, and the best way to keep them under control is by promptly documenting or reporting them using a standardized system such as the AERS.
Oracle's Adverse Effect Reporting System provides pharmaceutical companies the much needed control that they need in managing adverse drug reactions. It is a powerful and highly automated solution that provides clear data visibility to drug manufacturers, allowing them to efficiently monitor adverse events with precise data and easy to use features.
Drug manufacturers can benefit greatly with this very powerful and flexible drug safety monitoring and adverse event management system from Oracle. Above all, with the Oracle AERS implemented in every pharmaceutical company's system, consumers and patients can be assured that today's medicines are made even safer, without compromising their effectiveness.
No comments:
Post a Comment